<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00781248</url>
  </required_header>
  <id_info>
    <org_study_id>NV-NGS-06-001</org_study_id>
    <nct_id>NCT00781248</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of the NG Shield, a Device Intended to Reduce Pain and Discomfort Level Related to Nasogasstric Tube Usage</brief_title>
  <official_title>Evaluation of Safety and Efficacy of the NasoGastric Shield (NG Shield) in Healthy Subjects With Indwelling Nasogastric Tube</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanovibronix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanovibronix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study i to demonstrate the safety and efficacy of a device that intends to
      reduce pain/discomfort related to nasogfastric tube usage by reducing the friction between
      the tube and internal orifice (nose and pharynx)using micro vibrations
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain/discomfort levelusing flicker scale (1-10 scale)during indwelling phase</measure>
    <time_frame>every 30 minutes for 6 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>safety of device usage</measure>
    <time_frame>6 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain/Dicomfort during insertion and removal of the nasogastric tube</measure>
    <time_frame>at t=0h and t=6h</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Intubation, Nasogastric</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>starting with active NG Shield</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Starting with inactive NG Shield</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NG Shield</intervention_name>
    <description>A device to reduce pain/discomfort related to nasogastric tube usage</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is in good health and able to undergoes the NG tube insertion procedure,
             according to the PI decision

          2. Subject is able to understand and answer the pain and discomfort questionnaires

          3. Subject has been fasting for at least 12h prior to the insertion phase

          4. Subject underwent a physical examination by the PI

          5. Subject able, agrees and signs the Inform Consent Form (ICF)

        Exclusion Criteria:

          1. Subject has any history of dysphagia or esophageal disease

          2. Subject used anti pain medications during the last week prior to the study date

          3. Subject used Antibiotics during the last week prior to the study date

          4. Subject with Asthma

          5. Subject with chronic or acute nasal or throat disorder

          6. Subject who suffered from upper respiratory infection at least 7 days prior to the
             insertion procedure

          7. Any pain from other source prior to the initiation of the study procedure according to
             the PI judgment and decision

          8. Subject has any condition, which precludes compliance with study and/or device
             instruction for use

          9. Subject is currently participating in another clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shmuel Adler, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>&quot;Bikur Cholim&quot; Hospital, Jerusalem ISRAEL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>&quot;Bikur Cholim&quot; Hospital</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2008</study_first_submitted>
  <study_first_submitted_qc>October 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2008</study_first_posted>
  <last_update_submitted>March 24, 2009</last_update_submitted>
  <last_update_submitted_qc>March 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Dagan Harris VP Clinical Affairs</name_title>
    <organization>NanoVibronix</organization>
  </responsible_party>
  <keyword>enteral feeding</keyword>
  <keyword>Subject who requires nasogastric tube</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

